State Street Corp Collegium Pharmaceutical, Inc Transaction History

State Street Corp

  • $2.21 Trillion
  • Q1 2024

A detailed history of State Street Corp transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, State Street Corp holds 1,319,055 shares of COLL stock, worth $42.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,319,055
Previous 1,313,875 0.39%
Holding current value
$42.7 Million
Previous $40.4 Million 26.62%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$31.23 - $40.91 $161,771 - $211,913
5,180 Added 0.39%
1,319,055 $51.2 Million
Q4 2023

Feb 14, 2024
BUY
$21.16 - $30.8 $494,699 - $720,073
23,379 Added 1.81%
1,313,875 $40.4 Million
Q3 2023

Nov 14, 2023
BUY
$21.23 - $24.28 $488,863 - $559,095
23,027 Added 1.82%
1,290,496 $28.8 Million
Q2 2023

Aug 14, 2023
SELL
$21.06 - $24.0 $1.79 Million - $2.05 Million
-85,223 Reduced 6.3%
1,267,469 $27.2 Million
Q1 2023

May 15, 2023
BUY
$23.0 - $29.88 $1.48 Million - $1.93 Million
64,478 Added 5.01%
1,352,692 $32.5 Million
Q4 2022

Feb 14, 2023
SELL
$16.14 - $23.55 $1.2 Million - $1.75 Million
-74,448 Reduced 5.46%
1,288,214 $29.9 Million
Q3 2022

Nov 15, 2022
SELL
$15.46 - $20.1 $433,359 - $563,423
-28,031 Reduced 2.02%
1,362,662 $21.8 Million
Q2 2022

Aug 15, 2022
BUY
$14.22 - $20.88 $1.17 Million - $1.72 Million
82,526 Added 6.31%
1,390,693 $24.6 Million
Q1 2022

May 16, 2022
BUY
$17.2 - $22.5 $2.84 Million - $3.72 Million
165,144 Added 14.45%
1,308,167 $26.6 Million
Q4 2021

Feb 14, 2022
SELL
$17.5 - $21.35 $151,182 - $184,442
-8,639 Reduced 0.75%
1,143,023 $21.4 Million
Q3 2021

Nov 15, 2021
SELL
$17.75 - $25.39 $49,007 - $70,101
-2,761 Reduced 0.24%
1,151,662 $22.7 Million
Q2 2021

Aug 16, 2021
BUY
$21.74 - $25.28 $1.27 Million - $1.47 Million
58,221 Added 5.31%
1,154,423 $27.3 Million
Q1 2021

May 17, 2021
BUY
$19.25 - $26.1 $6.41 Million - $8.68 Million
332,734 Added 43.58%
1,096,202 $26 Million
Q4 2020

Feb 16, 2021
BUY
$17.83 - $22.29 $194,471 - $243,117
10,907 Added 1.45%
763,468 $15.3 Million
Q3 2020

Nov 10, 2020
SELL
$15.78 - $20.82 $987,543 - $1.3 Million
-62,582 Reduced 7.68%
752,561 $15.7 Million
Q2 2020

Aug 14, 2020
BUY
$15.49 - $23.51 $1.63 Million - $2.48 Million
105,337 Added 14.84%
815,143 $14.3 Million
Q1 2020

May 11, 2020
BUY
$13.89 - $25.45 $9.86 Million - $18.1 Million
709,806 New
709,806 $11.6 Million

Others Institutions Holding COLL

# of Institutions
231
Shares Held
39.5M
Call Options Held
104K
Put Options Held
15.4K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.1B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email